Market Place
Sourcing Support
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
01 Jun 2023 //
GLOBENEWSWIRE
Elicio Therapeutics Enters Into Merger Agreement with Angion Biomedica
17 Jan 2023 //
BIOSPACE
Elicio Therapeutics and Angion Enter into Definitive Merger Agreement
17 Jan 2023 //
GLOBENEWSWIRE
Cancer vaccine developer jumps to Nasdaq via reverse merger
17 Jan 2023 //
ENDPTS
Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
21 Dec 2022 //
GLOBENEWSWIRE
Angion Reports Second Quarter 2022 Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Angion hangs up `for sale` sign, stops drug development work
27 Jul 2022 //
FIERCEBIOTECH
Angion Announces Process to Explore Strategic Alternatives for Shareholder Value
25 Jul 2022 //
GLOBENEWSWIRE
Anguish for Angion as safety signal sinks kidney disease trial
30 Jun 2022 //
FIERCEBIOTECH
Angion Announces Discontinuation of PII Trial of ANG-3070 in PPKD
29 Jun 2022 //
GLOBENEWSWIRE
Angion Reports First Quarter 2022 Financial Results
16 May 2022 //
GLOBENEWSWIRE
Angion Announces Phase 1b Trial of ANG-3070 in IPF
16 May 2022 //
GLOBENEWSWIRE
Angion Announces Participation in Upcoming Investment Conference
14 Apr 2022 //
GLOBENEWSWIRE
Angion Provides Corporate Update and Reports Full Year 2021 Financial Results
30 Mar 2022 //
GLOBENEWSWIRE
Angion Announces Participation in Upcoming Investment Conferences
28 Feb 2022 //
GLOBENEWSWIRE
Angion Provides Corporate Update; Participation in Upcoming Investor Conference
04 Jan 2022 //
GLOBENEWSWIRE
Angion Biomedica, RedHill Biopharma leads healthcare gainers Biofrontera, Biogen
30 Dec 2021 //
SEEKINGALPHA
Snakebit Angion reports another miss for lead program; shifts `primary focus`
11 Dec 2021 //
ENDPTS
Vifor Pharma and Angion report topline results from phase-II trial of ANG-3777
10 Dec 2021 //
BUSINESSWIRE
Angion &Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777
09 Dec 2021 //
GLOBENEWSWIRE
Angion Provides Corporate Update and Reports Q3 2021 Financial Results
12 Nov 2021 //
GLOBENEWSWIRE
Angion Presents Multiple Posters on ANG-3070 at Kidney Week 2021
04 Nov 2021 //
GLOBENEWSWIRE
Shares down after Angion`s leading med fails again
28 Oct 2021 //
FIERCEBIOTECH
Angion’s kidney transplant dream dies
27 Oct 2021 //
EVALUATE
Angion`s organ damage drug strikes out again
27 Oct 2021 //
ENDPTS
Angion Hosting Research & Development Day on ANG-3070fo Lung and Kidney Fibrosis
07 Sep 2021 //
BIOSPACE
Angion Biomedica Corp. Announces Closing of $117 Million Initial Public Offering
09 Feb 2021 //
GLOBENEWSWIRE
Vifor Pharma, Angion Sign License Agreement for Commercialization of ANG-3777
11 Nov 2020 //
PHARMTECH
Vifor Pharma & Angion Sign License Agreement for ANG-3777
09 Nov 2020 //
BUSINESSWIRE
Angion to Present Multiple Posters at Kidney Week 2020
09 Oct 2020 //
GLOBENEWSWIRE
Angion Initiates Phase 2 Clinical Trial of ANG-3777 in Patients
07 Jul 2020 //
GLOBENEWSWIRE
Angion to Present Results from Multiple Preclinical and Health Economic Studies
29 May 2020 //
GLOBENEWSWIRE
